Jonathan Goldman, MD is a professor of medicine at the David Geffen School of Medicine at University of California, Los Angeles. He specializes in lung cancer, hematology, solid tumors, and early drug development.
Peripheral Neuropathy Treatable With Teliso-V in C–Met-High NSCLC
Toxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to Jonathan Goldman, MD.
Belzutifan May Lengthen Quality-Adjusted Survival in Advanced RCC
KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCC
Neoantigen Vaccine Shows Promise in Mutated Renal Cell Carcinoma
ADCs Are “Legos,” Customize Cancer Treatment By Target, Safety